Countries from Latin America and the Caribbean have this year formally started talks on creating a new regional medicines and devices regulator. The initiative has the potential to bring benefits for companies and patients, including reduced regulatory burden, an easier route to market and increased safety, quality and efficacy for products. However, experts warn that it could harm competitiveness of the region with increased bureaucracy and costs if the initiative is poorly managed.
Latin America And Caribbean Move Towards Creating A New Regional Regulator
Industry support for a new regional regulator for Latin America and the Caribbean is cautious and experts warn that it could harm competitiveness of the region.
